A plan to slash drug review times at the Food and Drug Administration is sparking deep concerns among agency staffers and ...
The abortion pill mifepristone has long been at the center of heated political discussions. But a new review suggests that ...
FDA scientists appear poised to sign off on the company’s proposal, according to a preliminary review posted by the agency ...
Study: FDA regulation of abortion drug mifepristone from 2011 to 2023 shaped by evidence and caution
An analysis of internal Food and Drug Administration documents by researchers at the Johns Hopkins Bloomberg School of Public Health finds that the agency generally followed cautious and ...
A plan to slash Food and Drug Administration drug review times is raising alarms at the public health agency that's been ...
Soon after the FDA’s guidance release, two other major AI announcements also hit the news: Utah began a first-in-the-nation pilot with Doctronic for autonomous AI prescription refills, and OpenAI ...
The FDA granted orphan drug designation to zavabresib, an investigational therapy for the treatment of myelofibrosis, a rare ...
PROVIDENCE, R.I., Dec. 8, 2025 /PRNewswire/ -- EpiVax, Inc., with U.S. Food and Drug Administration (FDA) and CUBRC, Inc. (Buffalo, NY) scientist collaborators ...
The Trump administration's elevation of a vaccine skeptic to lead a high-profile office within the Food and Drug Administration is raising alarm among multiple senior FDA officials, who told CBS News ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback